Travere Therapeutics, Inc. Insider Transactions
Travere Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 15,000 @ $17.22 | $258,278 | 54,927 | 12/26/2024 | 12/27/2024 | |
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 12,090 @ $18.30 | $221,258 | 54,927 | 11/25/2024 | 11/25/2024 | |
|
LYONS GARY A
Director |
Sell | 18,821 @ $15.15 | $285,227 | 51,000 | 10/04/2024 | 10/04/2024 | |
|
LYONS GARY A
Director |
Sell | 21,179 @ $14.35 | $303,874 | 69,821 | 10/04/2024 | 10/04/2024 | |
|
Meckler Jeffrey A
Director |
Sell | 40,000 @ $14.06 | $562,324 | 81,000 | 09/30/2024 | 09/30/2024 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 684 @ $12.98 | $8,878 | 61,949 | 09/10/2024 | 09/10/2024 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 2,490 @ $11.52 | $28,685 | 74,595 | 09/09/2024 | 09/09/2024 | |
|
Heerma Peter
CHIEF COMMERCIAL OFFICER |
Sell | 2,191 @ $11.52 | $25,240 | 107,958 | 09/09/2024 | 09/09/2024 | |
|
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER |
Sell | 21,125 @ $11.52 | $243,360 | 361,975 | 09/09/2024 | 09/09/2024 | |
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY |
Sell | 4,387 @ $11.52 | $50,538 | 78,633 | 09/09/2024 | 09/09/2024 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 2,191 @ $11.52 | $25,240 | 62,633 | 09/09/2024 | 09/09/2024 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 4,387 @ $11.52 | $50,538 | 84,455 | 09/09/2024 | 09/09/2024 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 514 @ $9.51 | $4,888 | 70,335 | 09/04/2024 | 09/05/2024 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 54 @ $6.74 | $364 | 70,849 | 04/11/2024 | 04/12/2024 | |
|
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER |
Sell | 9,106 @ $8.53 | $77,693 | 360,616 | 02/01/2024 | 02/02/2024 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 2,174 @ $8.53 | $18,548 | 83,310 | 02/01/2024 | 02/02/2024 | |
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 2,820 @ $8.53 | $24,058 | 52,017 | 02/01/2024 | 02/02/2024 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 2,590 @ $8.86 | $22,947 | 80,720 | 02/01/2024 | 02/02/2024 | |
|
Heerma Peter
CHIEF COMMERCIAL OFFICER |
Sell | 4,195 @ $8.53 | $35,789 | 99,503 | 02/01/2024 | 02/02/2024 | |
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY |
Sell | 2,590 @ $8.86 | $22,947 | 76,270 | 02/01/2024 | 02/02/2024 |
Travere Therapeutics, Inc. FAQ's
Who is on Travere Therapeutics, Inc.'s Insider Roster?
The list of insiders at Travere Therapeutics, Inc. includes ROTE WILLIAM E., REED ELIZABETH E, Cline Christopher R., Calvin Sandra, Dube Eric M, Heerma Peter, Inrig Jula, Meckler Jeffrey A, LYONS GARY A.
How much insider selling is happening at Travere Therapeutics, Inc.?
Insiders have sold a total of 202,089 Travere Therapeutics, Inc. shares in the last 12 months for a total of 2.57 M sold.
Which Travere Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Travere Therapeutics, Inc. shares in the last 12 months: ROTE WILLIAM E. ($110,509), REED ELIZABETH E ($110,509), Cline Christopher R. ($74,244), Calvin Sandra ($511,846), Dube Eric M ($480,337), Heerma Peter ($75,167), Inrig Jula ($52,665), Meckler Jeffrey A ($562,324), LYONS GARY A ($589,101),